Karí Syrjänen

Prof. Kari Syrjänen has retired as Chief Medical Director but continues as Chairman of the Scientific Advisory Board of BIOHIT Oyj (Helsinki, Finland), with the main current engagement as President and CEO of his company, SMW Consultants Ltd (est. 2003). Before this, he served some 40 years in different academic positions, e.g. as Professor of Pathology, Head of Clinical Pathology, and Dean of the Medical Faculty (UEF). He is one of the pioneers in HPV research, with 981 published original papers, reviews and book chapters as well as 531 other scientific communications. He has coordinated 3 European Commission (EC)-funded international multi-center studies (a Nobel laureate among partners), supervised 25 doctoral thesis (domestic and abroad), and published 9 international textbooks. His research has received over 37.400 citations in the literature, with current Hirsch Index (HI) of 97 (i10 index 623). He has participated as an invited speaker in 300 international congresses (with over 500 oral presentations), and as organizing committee member in over 40 of those. In 2013, KS was appointed as Editor-in-Chief, Acta Cytologica (Karger). Prof. Syrjänen is a Honorary Member of the American- (ASCPC), Italian- (ISCPC) and Hungarian (HSCPC) Society of Cervical Pathology and Colposcopy. In 2006, he received EUROGIN Distinguished Service Award, and in 2010, the Maurice Goldblatt Award (from IAC). He is also the first recipient of the IPVS Lifetime Achievement Award from the International Papillomavirus Society (2015). In 2022, he was invited as an Honorary member of the Finnish Society of Clinical Cytology (FSCC).